EconomyMarkets

FDA says five people in U.S. had allergic reactions after Pfizer shot By Reuters

© Reuters. Covid-19 vaccines are adminstered at Massachusetts General Hospital in Boston

NEW YORK (Reuters) – Around five recipients of Pfizer Inc (NYSE:) and BioNTech SE (NASDAQ:)’s COVID-19 vaccine in the United States have had allergic reactions this week, a top U.S. Food and Drug Administration official said on Friday during a press conference.

Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said that a chemical called polyetheylene glycol that is an ingredient in both the Pfizer vaccine and the Moderna (NASDAQ:) Inc vaccine authorized on Friday “could be the culprit” causing the reactions.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


Source link

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button